Lab Tests

Umbrella Health Care System - Labtests

Umbrella Health Care Systems medical labs are state of the art lab services , we use several reference labs to bring you best price and precise lab work, you can feel free to order any La...

All lab tests include $6 Physician's fee.
$6 fee is collected on behalf of affiliated physicians oversight for lab testing, lab results may require physicians follow-up services, UmbrellaMD will collect this fee for each order and it‚s non-refundable.

HEPATITIS C AB W/REFL TO HCV RNA, QN, PCR

$ 40.00

Hepatitis C Antibody Test What are the other names for this test? Hepatitis C test What is a Hepatitis C Antibody test? A hepatitis C antibody test can determine antibodies in response to the hepatitis C virus in your blood. Antibodies are proteins developed by your immune system. Antibodies help to prevent your body against infection, viruses, or bacteria. Hepatitis C is a viral infection that leads to liver inflammation or liver damage. It may transmit through several ways, like from contaminated blood. The Hepatitis antibody test is the first test to see whether you have been infected with HCV. Hepatitis C can divide into two; Acute hepatitis C and Chronic Hepatitis C. Acute hepatitis C: This will occur during the initial six months of exposure to the virus. Acute hepatitis does not show symptoms. Most people didn't think they possessed this infection. One-fourth of people recover from the virus as the immune system prevents your body from HCV infection. Chronic hepatitis C: This type of hepatitis C is produced when your immune system loses the capacity to fight the virus. The cycle of developing acute to chronic hepatitis C often happens in about 70% to 85% of patients. You may need to diagnose chronic hepatitis C before it leads to complications, such as liver cancer, liver damage, or disease. What is the purpose of this test? A hepatitis C antibody test helps to see whether you have an infection. A hepatitis C test may use to:   Screen HCV (hepatitis C virus) from other hepatitis, such as hepatitis A and hepatitis B. Screen for acute hepatitis C as it does not show symptoms. This test helps to detect hepatitis C before liver damage. Diagnose HCV if you are experiencing symptoms of liver failure. See the risks for developing HCV infection in a pregnant woman. Monitor your treatment if you have been infected with hepatitis C. When do I need to take this test? The presence of the hepatitis C virus leads to long-term infection, also known as chronic hepatitis C. Hepatitis C does not appear for several years in the body till the virus causes liver damage. You may need this at least once a year if you are 18 or above to screen for hepatitis C. Your healthcare provider recommends the hepatitis C antibody test if you are experiencing symptoms of liver disease. Symptoms of liver disease   Loss of appetite Itchy skin Losing weight Deposition of fluid in the abdomen Bleeding and bruising happen Eyes and skin color turn yellow (jaundice) Swelling in the legs Fatigue Spider shape blood vessels appear on your skin Sleepy and lethargic feeling Confusion Urine color changes to dark Book an online order for a hepatitis C antibody test at an affordable cost. The acute phase develops first before the chronic hepatitis C infection. You may have a low chance of symptoms of acute hepatitis C and generally remain undetectable. Some signs may include jaundice with nausea, fever, muscle aches, and fatigue. After two to three months of exposure to the virus, symptoms of acute hepatitis show up and remain there till within two weeks to three months. HCV can also recover in some people in the acute phase before the chronic virus. This condition is called spontaneous viral clearance. It does not always happen that acute hepatitis C goes to chronic infection. Hepatitis C may spread to other people in many ways, including   Sharing of the needle to take injections of drugs If you perform sex with an already infected person from the hepatitis C virus. Working in a healthcare center where you may be exposed to contaminated blood. What is the procedure for hepatitis C antibody test?   The sample depends on the test type your provider recommends to you. You may need to provide a blood sample, urine sample, or swab from your throat or nasal. For the blood test, the following are the steps of a rubella test that include:   Your provider will ask you to stay relaxed and calm before the test. Take a seat in front of your provider and remove your cloth from one of the arms. A small needle will inject into the vein in your arm. Your blood sample will collect in a test tube A little discomfort or pain may happen during the test or at the time of injection of the needle. Regular activities may resume after the test. This test will finish within five minutes. How do I need to prepare for this test? A hepatitis C antibody test does not need any specific preparation. You may eat or drink if you have only this test. But when your provider asks for other blood tests, you may need to fast for at least several hours. You can inform your provider about medicines, supplements, or vitamins you use. Do not avoid your medication without the prescription of your doctor. Are there any risks involved in this test?   A hepatitis C antibody test contains low risks when you give a blood sample to your provider. Vein differs from person to person. You may experience low risks when the needle injects into your vein, include   Infection Bruising Extreme Bleeding Slight pain Hematoma (Deposition of blood under the skin)   What do the test results indicate? The antibodies developed due to hepatitis C appear after 12 weeks of infection. Your test results will be delivered to you within a few days. The hepatitis C antibody test results depend on factors such as gender, age, medical history, and family history of hepatitis C. Negative result: The negative test results indicate that you have no antibodies in your blood and show no hepatitis C in your body. Positive result: The positive test result means antibodies develop in response to hepatitis C, indicating that you have hepatitis C. Your provider will recommend another test to confirm HCV. Learn about your Hepatitis C antibody test results with a professionally verified doctor through an online meetup. What additional tests do I need along with this test? If your test result for the Hepatitis C antibody test is positive, you may need some other tests, such as hepatitis C RNA and Genotype test.   Hepatitis C RNA: RNA is a genetic material from HCV that may present in your blood. Your provider will use this test to find the virus amount in your blood. Qualitative tests may help to see the presence of HCV RNA. Quantitative tests determine the HCV RNA amount. Your provider will understand the HCV amount that helps in treatment. Genotype test: Hepatitis C consists of six different forms. These are known as strains or genotypes. The strain will decide the treatment for hepatitis C. This test will help your provider to give you the required treatment if you have experienced HCV.  Your provider will also recommend liver function tests to diagnose your liver. What are the risk factors for hepatitis C? The following are risk factors for hepatitis C that you should consider:   Conducting a blood transfusion or organ transplant earlier than July 1992 If you are the person having kidney dialysis If you are a child whose mother has experienced hepatitis C. Having recent or current use of drugs through injection. Having an HIV infection Performing an unprotected sex Expose to a person who already has infected with the virus If you are pregnant Taking blood from the donor containing HCV Getting a tattoo on the body in an unclean environment with contaminated apparatus. Having concentrated clotting factors earlier than 1987

HEPATITIS C AB W/REFL TO HCV RNA, QN, PCR (REFL)

$ 40.00

"Clinical Significance Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR (REFL) - Hepatitis C Virus (HCV) is a major cause of hepatitis. The clinical symptoms of an HCV infection are variable. Infection with HCV results in a chronic infection in 50 to 80% of cases. The ""window"" between HCV acquisition and seroreactivity is highly variable; up to six months. Preferred Specimen(s) 4 mL serum Alternative Specimen(s) Plasma collected in: EDTA (lavender-top) tube Minimum Volume 3 mL Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 72 hours Refrigerated: 14 days Frozen: 30 days Reject Criteria Gross hemolysis • Grossly lipemic Includes This is a client specific reflex test. Reflex criteria has been pre-defined by the ordering physician. Additional testing will be performed at an additional charge. Methodology Immunoassay (IA) Reference Range(s) Hepatitis C Antibody (REFL)    Non-Reactive Index    <1.00

HEPATITIS C AB W/RFL RNA, PCR W/RFL GENOTYPE,LIPA

$ 40.00

"Clinical Significance Hepatitis C Antibody with Reflex to HCV RNA,PCR w/Reflex to Genotype, LiPA - Hepatitis C Virus (HCV) is the major cause of hepatitis. Making positive HCV Ab tests reflex to confirmatory molecular testing is necessary to confirm active HCV infection. Providing a second reflex to perform genotyping on HCV isolates when RNA is detected is also a necessary step before starting therapy. This double reflex will reduce the percentage of antibody-positive patients who lack appropriate confirmatory RNA testing and who do not have genotype testing performed. Preferred Specimen(s) 2.5 mL serum collected in each of 2 Serum Separator Tubes (SST®) Alternative Specimen(s) Plasma collected in each of 2 EDTA (lavender-top) tubes Minimum Volume 2 mL (x2) Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 72 hours Refrigerated: 14 days Frozen: 30 days Reject Criteria Gross hemolysis • Grossly lipemic • Red-top tube (no gel) • Heparinized plasma Includes If Hepatitis C Antibody is Reactive, then Hepatitis C Viral RNA, Quantitative, Real-Time PCR will be performed at an additional charge (CPT code(s): 87522). If Hepatitis C Viral RNA, Quantitative, Real-Time PCR is ≥300 IU/mL, then Hepatitis C Viral RNA Genotype, LiPA will be performed at an additional charge (CPT code(s): 87902). Methodology Immunoassay (IA) Reference Range(s) Hepatitis C Antibody    Non-Reactive Index    <1.00 Alternative Name(s) HCV with Reflex,HCV Antibody,Hepatitis C RNA Genotype,HCV RNA Genotype, LIPA

Herpes Simplex Virus 1 and 2 HSV 1/2 IGG,TYPE SPECIFIC AB

$ 44.00

"Clinical Significance Herpes Simplex Virus 1 and 2 (IgG), Type-Specific Antibodies - Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV Type 2 is more commonly associated with genital tract and neonatal infections, while HSV Type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients. Preferred Specimen(s) 1 mL serum Minimum Volume 0.5 mL Transport Container Transport tube Transport Temperature Room temperature Specimen Stability Room temperature: 7 days Refrigerated: 14 days Frozen: 30 days   Reject Criteria Gross hemolysis • Grossly lipemic • Plasma Methodology Immunoassay (IA) Reference Range(s) Index    Interpretation <0.90    Negative 0.90-1.09    Equivocal >1.09    PositiveThis assay utilizes recombinant type-specific antigens to differentiate HSV-1 from HSV-2 infections. A index positive result cannot distinguish between recent and past infection. If recent HSV infection is suspected but the results are negative or equivocal, the assay should be repeated in 4-6 weeks. The performance index characteristics of the assay have not been established for pediatric populations, immunocompromised patients, or neonatal screening.

HERRING (F205) IGE

$ 21.00

Preferred Specimen(s) 0.3 mL serum Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 14 days Refrigerated: 14 days Frozen: 30 days

HETEROPHILE, MONO SCREEN

$ 30.00

"Clinical Significance Heterophile, Mono Screen - Heterophile antibodies, in patients with infectious mononucleosis, may be present as early as the fourth day of illness, and by the twenty-first day of illness, 90% of patients will exhibit a positive test. The Epstein-Barr virus causes infectious mononucleosis. Preferred Specimen(s) 1 mL serum Minimum Volume 0.2 mL Transport Container Transport tube Specimen Stability Room temperature: 4 days Refrigerated: 7 days Frozen: 30 days Reject Criteria Gross hemolysis Methodology Agglutination Reference Range(s) Negative Alternative Name(s) Infectious Mononucleosis,Mono Screen

HETEROPHILE, MONO SCREEN (REFL)

$ 30.00

"linical Significance Heterophile, Mono Screen (REFL) - Heterophile antibodies, in patients with infectious mononucleosis, may be present as early as the fourth day of illness, and by the twenty-first day of illness, 90% of patients will exhibit a positive test. The Epstein-Barr virus causes infectious mononucleosis. Preferred Specimen(s) 1 mL serum Minimum Volume 0.2 mL Transport Container Transport tube Transport Temperature Room temperature Specimen Stability Room temperature: 4 days Refrigerated: 7 days Frozen: 30 days Reject Criteria Gross hemolysis • Gross lipemia • Plasma Includes This is a client specific reflex test. Reflex criteria has been pre-defined by the ordering physician. Additional testing will be performed at an additional charge. Methodology Agglutination (Qualitative Result Only) Reference Range(s) Negative Alternative Name(s) Infectious Mononucleosis,Mono Screen

HICKORY/PECAN TREE (T22) IGE

$ 21.00

Preferred Specimen(s) 0.3 mL serum Minimum Volume 0.15 mL/allergen Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 14 days Refrigerated: 14 days Frozen: 30 days

HIV 1 RNA, QL REAL TIME PCR

$ 219.00

"Clinical Significance HIV-1 RNA, Qualitative, Real-Time PCR - HIV-1 Qualitative is an in vitro nucleic acid amplification test for the qualitative detection of human immunodeficiency virus type 1 (HIV-1) RNA in human serum and plasma by PCR. The test is intended to be used as an aid in diagnosis of HIV-1 infection. Detection of HIV-1 nucleic acid is indicative of HIV-1 infection. The presence of HIV-1 nucleic acid in the plasma or serum of individuals without antibodies to HIV-1 is indicative of acute or primary HIV-1 infection. The HIV-1 Qualitative PCR may also be used as an additional test to confirm the presence of HIV-1 infection in an individual with specimens reactive for HIV-1 antibodies or antigens. The assay may also be used as an aid in the diagnosis of infection with HIV-1 in pediatric subjects and pregnant women. This assay is not intended to be used for monitoring patient status, or for screening donors of blood, plasma, or human cells, tissues, and cellular and tissue-based products (HCT/Ps) for HIV. Preferred Specimen(s) 1.6 mL serum or plasma collected in an EDTA (lavender-top) tube or potassium EDTA (white-top) tube Minimum Volume 0.8 mL Collection Instructions Separate plasma or serum from the cells by centrifugation within 24 hours after collection. Transfer the specimen to a transport tube. Separated plasma or serum can be sent in the PPT/SST® but cannot be shipped frozen. Transport Container Transport tube Transport Temperature Frozen Specimen Stability Room temperature: 72 hours Refrigerated: 5 days Frozen: 42 days Reject Criteria Whole blood • Unspun PPT • Frozen plasma in PPT (white-top) tube in situ • Frozen serum in Serum Separator Tube (SST®) in situ

HIV 1 RNA, QN PCR W/REFLEX TO GENOTYPE

$ 369.00

"Clinical Significance HIV-1 RNA, Quantitative, PCR with Reflex to Genotype - Measurement of HIV-1 plasma levels (viral load) provides a direct assessment of viremia and should be used in conjunction with CD4+ T-cell counts. HIV-1 RNA, quantitation is useful in patients to assess prognosis, monitor progression of HIV-1 infection, determine when to initiate therapy, and monitor the effectiveness of antiretroviral therapy. Preferred Specimen(s) 2 mL plasma collected in each of two EDTA (lavender-top) tubes Alternative Specimen(s) Plasma collected in each of two PPT (white-top) tubes Minimum Volume 1 mL (x2) Collection Instructions Do not freeze whole blood or any samples stored in primary tube. Freshly drawn specimens (whole blood) may be stored at 2-25° C for up to 24 hours prior to centrifugation. Separate plasma from cells within 24 hours of collection by centrifugation. Follow manufacturer's instructions for collection tube handling. Transport Container Transport tube Transport Temperature Frozen Specimen Stability Room temperature: Unacceptable Refrigerated: 6 days Frozen: 42 days Reject Criteria Plasma received frozen in the plasma preparation tube (PPT) • Serum • Whole blood greater than 24 hours old • Frozen whole blood • Samples collected in sodium heparin (green-top), or lithium heparin (green-top) tube Includes If HIV-1 RNA, Quantitative, Real-Time PCR viral load is ≥400 copies/mL, then HIV-1 Genotype will be performed at an additional charge (CPT code(s): 87900, 87901). Methodology Real-Time Polymerase Chain Reaction Reference Range(s) HIV-1 RNA, QN, PCR    Not detected    copies/mL HIV-1 RNA, QN, PCR    Not detected    Log copies/mL    HIV-1 Genotype    See Laboratory Report      Alternative Name(s) HIV Quant,HIV-1 RNA,HIV Genotyping

HIV 1 RNA, QN PCR W/RFL GENO (RTI,PI,INTEGRASE)

$ 369.00

"Clinical Significance HIV-1 RNA, Quantitative, Real-Time PCR with Reflex to Genotype (RTI, PI, Integrase) - Monitor viral load in HIV-1 patients undergoing antiretroviral therapy and automatically reflex to drug resistance testing for PR, RT and Integrase drugs in patients failing to achieve or maintain virologic suppression. Preferred Specimen(s) 7 mL plasma collected in an EDTA (lavender-top) tube Alternative Specimen(s) Plasma collected in: PPT Potassium EDTA (white-top) tube Minimum Volume 3.7 mL Collection Instructions Do not freeze whole blood or any samples stored in primary tube. Freshly drawn specimens (whole blood) may be stored at 2-25° C for up to 24 hours prior to centrifugation. Separate plasma from cells within 24 hours of collection by centrifugation. Follow manufacturer's instructions for collection tube handling. Transport Container Transport tube Transport Temperature Frozen Specimen Stability Room temperature: Unacceptable Refrigerated: 6 days Frozen: 30 days Reject Criteria Serum • Non-centrifuged PPT • Frozen PPT (in situ) • Heparinized plasma Includes If HIV-1 RNA, Quantitative, Real-Time PCR viral load is >400 copies/mL, HIV-1 Genotype and HIV-1 Integrase Genotype will be performed at an additional charge (CPT code(s): 87900, 87901, 87906). Methodology Real-Time Polymerase Chain Reaction Reference Range(s) HIV-1 RNA, QN, PCR    Not detected    copies/mL HIV-1 RNA, QN, PCR    Not detected    Log copies/mL Alternative Name(s) Human Immunodeficiency Virus

HIV 1 RNA, QN REAL TIME PCR W/REFL TROPISM,UDS

$ 369.00

"Clinical Significance HIV-1 RNA, Quantitative Real-Time PCR with Reflex to Coreceptor Tropism,UDS - This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level or to monitor the effects of antiretroviral therapy by measuring changes in EDTA plasma HIV-1 RNA levels during the course of antiretroviral treatment. This test is not intended for use as a screening test for the presence of HIV-1 in blood or blood products or as a diagnostic test to confirm the presence of HIV-1 infection. Preferred Specimen(s) 3 mL plasma collected in an EDTA (lavender-top) tube Alternative Specimen(s) Plasma collected in: PPT potasium EDTA (white-top) tube Minimum Volume 2.5 mL Collection Instructions Do not freeze whole blood or any samples stored in primary tube. Freshly drawn specimens (whole blood) may be stored at 2-25° C for up to 24 hours prior to centrifugation. Separate plasma from cells within 24 hours of collection by centrifugation. Follow manufacturer's instructions for collection tube handling. Transport Container Transport tube Transport Temperature Frozen Specimen Stability Room temperature: Unacceptable Refrigerated: 5 days Frozen: 30 days Reject Criteria Gross hemolysis • Lipemia • Serum • Whole blood >24 hours old • Non-centrifuged PPT • Frozen PPT (in situ) • Heparinized plasma Includes If HIV-1 RNA, Quantitative, PCR is ≥1000 copies/mL, then HIV-1 Coreceptor Tropism, Ultradeep Sequencing will be performed at an additional charge (CPT code(s): 87906). Methodology Real-Time Polymerase Chain Reaction Reference Range(s) HIV-1 RNA, QN,PCR    Not detected    copies/mL HIV-1 RNA, QN, PCR    Not detected    Log copies/mL

HIV 1 RNA, QN REAL TIME PCR, CSF

$ 369.00

"Clinical Significance HIV-1 RNA, Quantitative, Real-Time PCR, CSF - This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level or to monitor the effects of antiretroviral therapy by measuring changes in EDTA plasma HIV-1 RNA levels during the course of anti-retroviral treatment. Preferred Specimen(s) 3 mL frozen CSF Minimum Volume 1.1 mL Collection Instructions Collect at least 3 mL CSF in a sterile screw-capped container. Do not use heparin tube for collection as heparin inhibits PCR. Ship CSF frozen. Transport Container Sterile leak-proof container Transport Temperature Frozen Specimen Stability Room temperature: 24 hours Refrigerated: 6 days Frozen: 42 days Reject Criteria Specimen collected using heparin as anticoagulant • Leaking, uncapped or broken containers • Frozen plasma received in PPT in situ Methodology Real-Time Polymerase Chain Reaction Assay Category The analytical performance characteristics of this assay have been determined by Quest Diagnostics. The modifications have not been cleared or approved by the FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes. Reference Range(s) HIV-1 RNA, QN PCR, CSF    Not Detected    Copies/mL HIV-1 RNA, QN PCR, CSF    Not Detected    Log copies/mL

HIV 1 RNA, QUANTITATIVE REAL TIME PCR

$ 369.00

"Clinical Significance HIV-1 RNA, Quantitative, Real-Time PCR - This test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of HIV-1 infected patients. The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level or to monitor the effects of antiretroviral therapy by measuring changes in EDTA plasma HIV-1 RNA levels during the course of antiretroviral treatment. Preferred Specimen(s) 3 mL plasma collected in an EDTA (lavender-top) or PPT (white-top) tube Minimum Volume 1 mL Collection Instructions Do not freeze whole blood or any samples stored in primary tube. Freshly drawn specimens (whole blood) may be stored at 2-25°C for up to 24 hours prior to centrifugation. Separate plasma from cells within 24 hours of collection by centrifugation. Follow manufacturer’s instructions for collection tube handling. Transport Container Transport tube Transport Temperature Frozen Specimen Stability Room temperature: Unacceptable Refrigerated: 6 days Frozen: 84 days Reject Criteria Received room temperature • Plasma received frozen in the plasma preparation tube (PPT) • Serum • Whole blood >24 hours old • Frozen whole blood Methodology Real-Time Polymerase Chain Reaction Reference Range(s) HIV-1 RNA, QN, PCR    Not detected    copies/mL HIV-1 RNA, QN, PCR    Not detected    Log copies/mL Alternative Name(s) HIV Viral Load,Viral Load, HIV

HIV-1, and HIV-2 (ANTIGEN/ANTIBODY,FOURTH GENERATION W/RFL)

$ 75.00

HIV-I and HIV-II (ANTIGEN/ANTIBODY, FOURTH GENERATION WITH REFLEX) What are the other names for this test? HIV antibody/antigen tests, HIV p24 antigen test, HIV antibody test, HIV test, HIV screening test What is the HIV Antibody test? An HIV (Human Immunodeficiency Virus) antibody test determines HIV-I and HIV-II antibodies in your blood. When you experience HIV infection, antibodies develop in your body. HIV is a virus that attacks cells in the immune system of your body. Your immune system consists of cells, organs, proteins, and tissues. These cells help to prevent infections, bacteria, and viruses. An HIV infection can weaken your immune system, which results in AIDS (late stage). Your body will lose the ability to fight infections and other diseases if the cells of your immune system decrease. If you diagnose HIV earlier, your provider may recommend specific medicines to decrease the risk for AIDS. Medical treatment also helps to reduce the chance of spreading HIV to other people. The HIV antibody test is the most accurate test to identify the disease of HIV infection. What are the two forms of HIV? HIV-II - It is often available throughout the world. HIV-II - It is usually in the western part of Africa. It also spreads to the U.S. What is the purpose of this test? An HIV antibody/antigen test often conducts to see antibodies and antigens in your blood. This fourth-generation HIV antibody test helps to detect an HIV p24 antigen that activates your immune system to fight this infection. When you have an HIV infection, these antigens appear in your blood more than antibodies. Your immune system develops antibodies, which are proteins to protect your body against bacteria and other diseases. The HIV test helps to detect if you have a chance to infect with HIV. When do I need an HIV antibody test? You may also need to take this test if you already had unprotected sex with a person. This test helps to diagnose if the HIV test results are positive. The Centers for Disease Control and Prevention (CDC) suggests the HIV antibody test at least once for every person aged 13 to 64. Your provider may ask for additional tests if you are at risk of severe infection.                                   Your provider also recommends the HIV test if you have experienced these conditions.   Unprotected sex - If you had performed unprotected sex with different partners, unprotected sex with any partner, men performed sex with men, or with outsiders.   Sex with an HIV-infected person - When you do vaginal or anal sex with a person having an HIV infection.   Sharing needles to take drugs - HIV infections spread with needle sharing in your body.   Pregnant - The testing is necessary for pregnant women during each pregnancy. Your provider asks to order this test even if the results of previous pregnancies were negative. HIV may pass to your baby during pregnancy and birth.   Diagnosed with sexually transmitted infection (STI) - The condition of STIs such as syphilis usually has the probability of high HIV infection. Syphilis is a bacterial infection that occurs due to sexual activity.   Working in the healthcare center - If you are a healthcare provider and come in contact with a contaminated needle or instrument, you may need to take this test during the exposure and after the upcoming 4 to 6 months. If you have the above conditions, you may need to take HIV test after every year. You can contact an online doctor to discuss the number of tests you need to conduct. Your healthcare provider recommends an HIV antibody test if you have symptoms of HIV-I and HIV-II, include   Pain in the muscles and joints Headache Unexpected Weight loss Pain in the mouth due to inflammation Diarrhea Cough Rash Extreme tiredness Fever Sore throat Night sweats Swelling in lymph glands, a type of small bean-shaped organs that filters elements in your body. It is in your neck, chest, abdomen, underarms, and groin (where the thigh meets your stomach).  What is the procedure for HIV antibody test? Your provider will determine what sample you may need to provide for this test. These samples may include blood from a vein or finger or saliva. The HIV test can perform in several ways:   Lab tests - Your provider collects a blood sample from your vein when you go to a lab. You may experience a little pain at the point in your vein from where the blood collects. A chance of bleeding or bruising may also occur, but generally, these signs do not last long. You will get your test report within a few days after you give the blood sample to your provider. For a saliva sample - your provider will rub an absorbent pad on your gums.   Rapid tests - Your provider will take blood from your finger, saliva, or urine. The test results appear within 30 minutes.   Home tests - It contains rapid self-test kits to collect a sample of saliva by yourself. You need to take a drop of blood from your finger for testing purposes. How do I need to prepare for an HIV test? Your provider will inform you about any specific instructions for the test until you do not need to prepare for the test. You can also talk with your provider if you are using medicines, vitamins, and supplements. Your provider may also ask you to avoid the intake of alcohol for at least 24 hours. A provider may inform you about your risk for HIV infection.   What are the risks of this test?   An HIV antibody test is a blood test that does not have a high risk. You may experience a little pain at the point in your vein from where the blood collects. A chance of bleeding or bruising may also occur, but generally, these signs do not last long. What additional tests may I need to conduct along with this test? Your healthcare provider may suggest tests for sexually transmitted infections (STIs). What factors may affect the HIV antibody test? If you tested earlier after the infection with HIV, you might get a false-negative and inaccurate result. What do HIV test results mean?   The test results for an HIV antibody test depend on age, gender, medical history, and other factors. Your lab test results may differ among laboratories. Each lab may use different measurement methods. A negative test result indicates that no antibodies are available in your body or you don’t have HIV. It is not a necessary signal that you don’t have HIV. You may experience an HIV infection because the test timing was not suitable, and you may need additional tests to judge conditions. Your healthcare provider will read your test results and inform you about more tests. If you experience negative test results on a rapid test or an at-home test and expose to HIV in: More than or equal to 90 days - You have no chance of an HIV infection Less than 90 days - You may need to repeat another test for HIV Positive test results indicate you have an HIV infection or antibodies are available in your blood. You may conduct more repeated tests to detect HIV disease. If you want to diagnose HIV infection in your body, you can place an online order. With this test, you can understand your medical conditions. For more laboratory lab tests, you can click here.  

HONEY BEE (I1) IGE

$ 21.00

Preferred Specimen(s) 0.3 mL serum Minimum Volume 0.15 mL/allergen Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 14 days Refrigerated: 14 days Frozen: 30 days

HORN BEAM (T209) IGE **

$ 21.00

Preferred Specimen(s) 0.3 mL serum Minimum Volume 0.15 mL/allergen Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 14 days Refrigerated: 14 days Frozen: 30 days

HORSE DANDER (E3) IGE

$ 21.00

Preferred Specimen(s) 0.3 mL serum Minimum Volume 0.15 mL/allergen Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 14 days Refrigerated: 14 days Frozen: 30 days

HORSEFLY (I204) IGE **

$ 21.00

Preferred Specimen(s) Minimum Volume 0.15 mL/allergen Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 14 days Refrigerated: 14 days Frozen: 30 days

HOUSE DUST (GREER) (H1) IGE

$ 21.00

Preferred Specimen(s) 0.3 mL serum Minimum Volume 0.15 mL/allergen Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 14 days Refrigerated: 14 days Frozen: 30 days

HOUSE DUST (HOLLISTER- STIER) (H2) IGE

$ 21.00

Clinical Significance House Dust (Hollister-Stier) (h2) IgE - This allergen-specific IgE antibody test quantifies an individual’s IgE response to house dust. It is an in vitro quantitative assay that is intended to be used in conjunction with other clinical information to aid in the diagnosis of allergic diseases [1]. While allergen-specific serum IgE testing is considered comparable to skin testing in many instances, both the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology recognize that allergen-specific serum IgE testing may be preferred in some clinical situations. These include 1) the presence of widespread skin disease, 2) the recent use of antihistamines or other medications that can affect the results of allergy skin tests, 3) uncooperative patients, and 4) medical history suggesting that allergen skin testing would pose a significant risk for a serious allergic reaction [1]. A definitive clinical diagnosis of allergy should not be based on the results of any single diagnostic method, but should be made by a trained healthcare provider after all clinical and laboratory findings have been evaluated. Preferred Specimen(s) 0.3 mL serum Minimum Volume 0.15 mL/allergen Transport Container Serum Separator Tube (SST®) Transport Temperature Room temperature Specimen Stability Room temperature: 14 days Refrigerated: 14 days Frozen: 30 days

hsCRP inflammation Marker C-reactive protein HS CRP

$ 44.00

HS CRP C-REACTIVE PROTEIN TEST What are the other names for this test? CRP for heart disease, Cardiac CRP, HS-CRP, C - reactive protein, serum  What is an HS C-reactive protein test? A high-sensitivity CRP (C-reactive protein) test is a blood test that determines the amount of C-reactive protein in your blood sample. C-reactive protein in your body develops by your liver. This test is more sensitive compared to the standard C-reactive protein test. This high-sensitivity test shows a few rises in CRP levels than a standard CRP test. An increase in CRP levels occurs due to the inflammation in your body. Abnormal or high levels of CRP indicate that you experience health problems that lead to inflammation in your body. The HS- CRP test does not show causes for inflammation or where it develops in your body.  Inflammation may be acute (temporary) or chronic (long-term). Acute Inflammation is generally helpful to prevent your tissues and heal them from an injury, infection, or another disease. If you have a cut on your skin that turns red, swells, and into pain for a short time. This condition is known as inflammation, which can also occur within your body.  The healthy tissues of your body may damage due to chronic inflammation, which stays in your body for a long time. Other factors, like chronic infections, autoimmune disorders, and other diseases, may lead to chronic inflammation. It may also develop due to repeated injury or irritation from smoking or other substances.  What is the purpose of this test? The HS-CRP test helps to indicate your risk of chronic heart disease. This test may conduct with a combination of other tests like lipid panel or other heart risk markers. This test is also helpful for those having a 10 to 20 % risk of developing a heart attack in the next ten years. According to the American Heart Association (AHA), the three risk factors for heart attack are: Age factor - The increasing age of men and women. Gender - Males have a high chance of heart attack. The American Heart Association writes that heart attack causes high risks of death in females.  Family history - If your parents already have heart disease, then children may also have a risk for heart problems.  Your healthcare provider recommends an HS-CRP test to diagnose: ● Infection from viruses or bacteria ● The risk of a heart disease ● The risk of a second heart attack ● Lung diseases, such as asthma ● Inflammatory bowel diseases ● Intestinal disorders, including Crohn’s disease and ulcerative colitis - a disease in which sensitivity occurs in the colon and rectum of your body. ● A chronic inflammatory disease, such as lupus or rheumatoid arthritis - is an autoimmune condition in which your immune system attacks healthy cells in your body, leading to inflammatory disease).  When do I need an HS-CRP test? You may also need to place an online order for this test if you experience infection from bacteria that include: ● Increased heartbeat ● Fever or chills ● Nausea and vomiting ● Increased breath The factors that may lead to heart attack disease, such as ● Smoking ● High cholesterol levels  ● Blood pressure ● Lack of physical activity ● Malnutrition or improper intake of diet ● Diabetes ● Overweight Your provider may also use this test to observe your conditions and treatment if you previously have been diagnosed with an infection or a chronic disease. High or low CRP levels may vary on levels of sensitivity or burning in your body. Your CRP level decreases when you see improvements in your health from inflammation disease. What is the procedure for the HS-CRP test? Your healthcare provider will ask you to provide a blood sample for the high-sensitivity C-reactive protein test. A needle injects into a vein in your arm. A small amount of blood collects in a test tube. Your provider applies a bandage to your vein where the needle injects. This test does not take time greater than 5 minutes. The HS-CRP test report receives within 1-2 days. How do I need to prepare for this test? You can inform your provider about medicines or supplements that you use. This medicine includes aspirin, ibuprofen, and non-steroidal anti-inflammatory drugs (NSAIDS). You can talk with your provider if you want to take any prescribed medication. What are the risks of the high-sensitivity C-reactive protein test? An HS-CRP test is a blood test that does not have a high risk. You may experience a little pain at the point in your vein from where the blood collects. A chance of bleeding or bruising may also occur, but generally, these signs do not last long. What do the test results indicate? The HS-CRP test results may vary on age, gender, family history, and other factors. This test can measure low CRP levels from 0.3 to 10 mg/L. A high level of HS-CRP in your blood can show the risk of heart attacks. People can also get another or second heart attack after the one when they have high CRP levels. According to the CDC (Center for Disease Control and Prevention) and the AHA (American Heart Association), you may need to repeat this test within two weeks if you have CRP levels higher than 10 mg/dL.  The HS-CRP test does not provide information about the causes of inflammation in your body. HS-C-reactive protein tests help to identify the risk for cardiovascular (heart) disease. It is possible that you may have high HS-CRP levels without any heart disease. You can get complete information about your test results by setting up an online talk with a doctor.  What additional tests do I need along with the HS-CRP test? Your healthcare provider may recommend the standard CRP test besides an HS-CRP test. A standard CRP test can measure high C-reactive protein to identify diseases that may cause sensitivity in your body. The CRP test range is between 8 to 1000 mg/L. Your provider will use this test to examine and detect sensitivity in your body.  You can visit here if you are looking for more laboratory tests and their information with e-consultation service.  

HSV 1 IGG, TYPE SPECIFIC AB

$ 19.00

"Clinical Significance Herpes Simplex Virus 1 (IgG), Type-Specific Antibody - Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV type 2 is more commonly associated with genital tract and neonatal infections, while HSV type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients. Preferred Specimen(s) 1 mL serum Minimum Volume 0.5 mL Transport Container Transport tube Transport Temperature Room temperature Specimen Stability Room temperature: 7 days Refrigerated: 14 days Frozen: 30 days   Reject Criteria Gross hemolysis • Grossly lipemic • Plasma Methodology Immunoassay (IA) Reference Range(s) Index    Interpretation <0.90    Negative 0.90-1.09    Equivocal >1.09    PositiveThis assay utilizes recombinant type-specific antigens to differentiate HSV-1 from HSV-2 infections. A index positive result cannot distinguish between recent and past infection. If recent HSV infection is suspected but the results are negative or equivocal, the assay should be repeated in 4-6 weeks. The performance index characteristics of the assay have not been established for pediatric populations, immunocompromised patients, or neonatal screening.

HSV 2 IGG, TYPE SPECIFIC AB

$ 19.00

"Clinical Significance Herpes Simplex Virus 2 (IgG), Type-Specific Antibody - Herpes Simplex Virus (HSV) is responsible for several clinically significant human viral diseases, with severity ranging from inapparent to fatal. Clinical manifestations include genital tract infections, neonatal herpes, meningoencephalitis, keratoconjunctivitis, and gingivostomatitis. There are two HSV serotypes that are closely related antigenically. HSV type 2 is more commonly associated with genital tract and neonatal infections, while HSV type 1 is more commonly associated with infections of non-genital sites. Specific typing is not usually required for diagnosis or treatment. The mean time to seroconversion using the type specific assay is 25 days. The performance of this assay has not been established for use in a pediatric population, for neonatal screening, or for testing of immunocompromised patients. Preferred Specimen(s) 1 mL serum Minimum Volume 0.5 mL Transport Container Transport tube Transport Temperature Room temperature Specimen Stability Room temperature: 7 days Refrigerated: 14 days Frozen: 30 days Reject Criteria Gross hemolysis • Grossly lipemic • Plasma Methodology Immunoassay (IA) Reference Range(s) Index    Interpretation <0.90    Negative 0.90-1.09    Equivocal >1.09    PositiveThis assay utilizes recombinant type-specific antigens to differentiate HSV-1 from HSV-2 infections. A index positive result cannot distinguish between recent and past infection. If recent HSV infection is suspected but the results are negative or equivocal, the assay should be repeated in 4-6 weeks. The performance index characteristics of the assay have not been established for pediatric populations, immunocompromised patients, or neonatal screening.

  How can we help you?